乳腺癌患者正常或良性腋窝淋巴结的超声造影能否识别显著的腋窝淋巴结负荷
该回顾性分析纳入2013至2018年腋窝超声正常或细针穿刺良性的乳腺癌患者,术前行超声造影引导前哨淋巴结活检。超声造影识别前哨淋巴结成功率90.7%,恶性诊断灵敏度55.77%,高负荷病变灵敏度77.78%高于低负荷病变32.00%,特异度100%。研究提示初始超声造影引导前哨淋巴结空心针活检良性者,手术结束时广泛腋窝病变的可能性低。
要点
- 超声造影引导前哨淋巴结空心针活检特异度100%,恶性者手术时72.4%有两个及以上宏转移。
- 高负荷病变灵敏度77.78%高于低负荷病变32.00%(OR=7.44,95%CI=2.16至25.62,P=.001)。
- 初始良性超声造影引导活检者手术时仅4.47%有两个及以上宏转移。
核心结论
- 病变存在时,超声造影引导前哨淋巴结空心针活检在腋窝灰阶超声正常的患者中识别淋巴结转移的灵敏度为55.77%。
- 本研究提示初始超声造影引导前哨淋巴结空心针活检良性者,手术结束时广泛腋窝病变的可能性低。
研究设计与样本
- 回顾性分析2013至2018年前瞻性收集的数据。
- 纳入腋窝超声正常或腋窝细针穿刺良性的乳腺癌患者,术前接受超声造影引导前哨淋巴结活检。
诊断标准与关键数值
- 超声造影成功识别前哨淋巴结186例(90.7%),其中163例(87.6%)获得明确诊断。
- 总体灵敏度55.77%,高负荷病变灵敏度77.78%,低负荷病变灵敏度32.00%(OR=7.44,95%CI=2.16至25.62,P=.001)。
- 特异度100%;阴性预测值总体82.84%,低负荷病变86.72%,高负荷病变94.87%。
- 初始超声造影引导前哨淋巴结空心针活检恶性者中72.4%手术结束时有两个及以上宏转移,初始良性者为4.47%。
临床应用与阅片要点
- 超声造影可用于术前识别前哨淋巴结并引导空心针活检,但灵敏度总体55.77%,低负荷病变仅32.00%,阴性结果不能排除低负荷转移。
- 初始超声造影引导活检良性者手术时广泛腋窝病变比例低(4.47%),可结合该信息评估腋窝处理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Contrast enhanced ultrasound (CEUS) of the axilla allows preoperative identification and biopsy of the sentinel lymph node. Our aims were to evaluate the accuracy of the CEUS procedure for identifying axillary lymph node metastases preoperatively and compare the volume of axillary metastases in patients with malignant versus benign CEUS guided core biopsy at end of primary surgical treatment.
METHODS: Retrospective analysis of prospectively collected data on patients with breast cancer with normal axillary ultrasound or benign axillary FNAC undergoing preoperatively CEUS guided sentinel lymph node biopsy between 2013 and 2018.
RESULTS: SLN was successfully identified by CEUS in 186 (90.7%) of patients with definitive diagnosis obtained in 163 (87.6%). Overall sensitivity was 55.77%, but significantly higher for high volume disease (77.78%) than for low volume disease (32.00%, odds ratio = 7.44, 95% CI = 2.16 to 25.62, p = .001) Specificity was 100%. NPV was 82.84% overall, 86.72% for low volume disease and 94.87 % for high volume disease. 72.4% of patients with initial malignant CEUS guided SLN core biopsy had two or more macrometastases at end of surgical treatment compared to 4.47% of patients with initial benign CEUS guided core biopsy.
CONCLUSION: When disease was present, CEUS guided sentinel lymph node core biopsy identify nodal metastases in 55.77% of patients with normal axillary grey scale ultrasound. This study suggests that the likelihood of extensive axillary disease at end of surgical treatment is low with an initial benign CEUS guided SLN core biopsy.
引用
- Nielsen Moody A, Cox K, Haigh I, et al. Does Contrast Enhanced Ultrasound (CEUS) of Normal/Benign Axillary Lymph Nodes in Patients with Breast Cancer Identify Significant Axillary Nodal Burden? Eur J Radiol. 2020. PMID: 33017774. doi:10.1016/j.ejrad.2020.109311
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。